RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0174 (−31.64%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Regenerative Medical Technology Group Inc. grew revenue 94.3% to $9.41M over the twelve months to Jun 30, 2026. Operating income fell 84.7% to $43.73K, moving the operating margin from 5.9% to 0.5%. Free cash flow was -$582.33K.
Revenue
$9.41M
+94.3% vs. a year earlier
Operating income
$43.73K
-84.7% vs. a year earlier
Free cash flow
-$582.33K
TTM Q2 2026
EPS, diluted
-$0.75
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $497.25K
- P/E ratio
- –
- Price to sales
- 0.05
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -117.11%
Fundamentals
- Revenue
- $9.41M
- Net income
- -$9.53M
- EPS, diluted
- -$0.75
- Free cash flow
- -$582.33K
- Book value per share
- -$2.97
- Diluted shares
- 13M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$9.41M+94.3% YoY
Gross profit
$5.63M+72.7% YoY
Operating income
$43.73K-84.7% YoY
Net income
-$9.53M
EPS, diluted
-$0.75
Free cash flow
-$582.33K
Reported periodTrailing twelve months